Write a reviewFor vendors
♡
Home / Investors / Michael Nally

Michael Nally

Venture Fund · Boston

About Michael Nally

Venture capital investor (CEO at Generate Biomedicines) based in Boston, Massachusetts. Focus areas include Health Care, Drug Discovery, Wellness. Invests at series a stage. Past investments include PPG Industries, MSD, Merck.

Investment focus

Stages
Series A
Sectors
Health CareDrug DiscoveryWellnessEnterprise SoftwareComputational BiologyEngineeringArtificial Intelligence (AI)BioinformaticsBiotechnologyPrecision MedicineClinical TrialsResearchConsumer SoftwareGenerative Tech/AIMedicalInformation TechnologyB2BMachine LearningPharmaceuticalsHealthcare Technology

Portfolio

No portfolio companies recorded yet; Michael Nally reports 4 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam D?Eaugelli

Venture Fund · San Francisco
Early Stage VentureSeries AHealth CareE-commerceSportsWellness+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits

Adam Valkin

Venture Fund · Newton
Series BEarly Stage VentureSeries AHealth CareDigital TherapeuticsE-commerceAccounting+16
60Investments
—Exits

Adeyemi Ajao

Accelerator · San Francisco
SeedEarly Stage VentureSeries AAdvertisingHealth CareTalent ManagementAutonomous Vehicles+16
60Investments
—Exits